| Primary |
| Product Used For Unknown Indication |
70.8% |
| Pain |
9.6% |
| Analgesic Therapy |
2.7% |
| Back Pain |
1.7% |
| Hypertension |
1.7% |
| Osteoarthritis |
1.7% |
| Depression |
1.0% |
| Drug Use For Unknown Indication |
1.0% |
| Hypermobility Syndrome |
1.0% |
| Myalgia |
1.0% |
| Neuralgia |
1.0% |
| Osteoporosis |
1.0% |
| Rheumatoid Arthritis |
1.0% |
| Abdominal Pain |
0.8% |
| Arthralgia |
0.8% |
| Drug Abuse |
0.7% |
| Headache |
0.7% |
| Neck Pain |
0.7% |
| Prophylaxis |
0.7% |
| Pain In Extremity |
0.5% |
|
| Drug Ineffective |
12.5% |
| Inadequate Analgesia |
10.0% |
| Vomiting |
10.0% |
| Convulsion |
7.5% |
| Overdose |
6.3% |
| Constipation |
5.0% |
| Hallucination |
5.0% |
| Nausea |
5.0% |
| Drug Abuse |
3.8% |
| Drug Interaction |
3.8% |
| Hallucination, Visual |
3.8% |
| Hypoglycaemia |
3.8% |
| Pain |
3.8% |
| Respiratory Depression |
3.8% |
| Suicide Attempt |
3.8% |
| Adrenal Insufficiency |
2.5% |
| Adverse Drug Reaction |
2.5% |
| Breakthrough Pain |
2.5% |
| Drug Effect Decreased |
2.5% |
| Drug Withdrawal Syndrome |
2.5% |
|
| Secondary |
| Product Used For Unknown Indication |
27.1% |
| Pain |
12.7% |
| Osteoarthritis |
11.0% |
| Hypermobility Syndrome |
8.6% |
| Myalgia |
8.6% |
| Osteoporosis |
8.6% |
| Rheumatoid Arthritis |
8.6% |
| Hypertension |
2.3% |
| Insomnia |
2.3% |
| Alcoholic Liver Disease |
1.2% |
| Constipation |
1.2% |
| Fibromyalgia |
1.2% |
| Gastritis Prophylaxis |
1.2% |
| Headache |
1.2% |
| Arthralgia |
0.9% |
| Back Pain |
0.9% |
| Depression |
0.9% |
| Abdominal Pain |
0.6% |
| Drug Abuse |
0.6% |
| Muscle Spasms |
0.6% |
|
| Drug Ineffective |
16.2% |
| Suicidal Ideation |
13.5% |
| Gastric Ulcer Haemorrhage |
10.8% |
| Adrenal Insufficiency |
5.4% |
| Confusional State |
5.4% |
| Negative Thoughts |
5.4% |
| Skin Toxicity |
5.4% |
| Tremor |
5.4% |
| Arteriosclerosis |
2.7% |
| C-reactive Protein Increased |
2.7% |
| Convulsion |
2.7% |
| Delusion |
2.7% |
| Drug Hypersensitivity |
2.7% |
| Drug Prescribing Error |
2.7% |
| Drug Withdrawal Syndrome |
2.7% |
| Feeling Abnormal |
2.7% |
| Flatulence |
2.7% |
| Gait Disturbance |
2.7% |
| Nausea |
2.7% |
| Overdose |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
58.8% |
| Pain |
21.2% |
| Breakthrough Pain |
6.5% |
| Analgesic Therapy |
5.9% |
| Back Pain |
2.4% |
| Osteoarthritis |
1.2% |
| Arthralgia |
0.6% |
| Blood Cholesterol Increased |
0.6% |
| Complex Regional Pain Syndrome |
0.6% |
| Intervertebral Disc Degeneration |
0.6% |
| Neck Pain |
0.6% |
| Neuralgia |
0.6% |
| Rib Fracture |
0.6% |
|
| Inadequate Analgesia |
22.4% |
| Nausea |
14.3% |
| Drug Ineffective |
12.2% |
| Drug Effect Decreased |
8.2% |
| Product Adhesion Issue |
6.1% |
| Application Site Rash |
4.1% |
| Malaise |
4.1% |
| Wrong Technique In Drug Usage Process |
4.1% |
| Accidental Overdose |
2.0% |
| Application Site Scab |
2.0% |
| Arthralgia |
2.0% |
| Breakthrough Pain |
2.0% |
| Drug Effect Increased |
2.0% |
| Drug Hypersensitivity |
2.0% |
| Drug Withdrawal Syndrome |
2.0% |
| Extra Dose Administered |
2.0% |
| Hypoaesthesia |
2.0% |
| Impaired Driving Ability |
2.0% |
| Overdose |
2.0% |
| Pain |
2.0% |
|
